Log In
Print
BCIQ
Print
Print this Print this
 

Soltamox, tamoxifen

  Manage Alerts
Collapse Summary General Information
Company Perrigo Co. plc
DescriptionLiquid formulation of tamoxifen citrate
Molecular Target Estrogen receptor
Mechanism of ActionEstrogen receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer; Treat hormonally sensitive breast cancer
Regulatory Designation
Partner Dara BioSciences Inc.; Mission Pharmacal Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$313.4M

$283.6M

$5.7M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today